Carnitine palmityltransferase II (CPT2) deficiency and migraine headache: Two case reports

Headache

Volumn 43, Issue 5, 2003, Pages 490-495

  Kabbouche, Marielle A ^a,b   Powers, Scott W ^a,b   Vockell, Anna Liisa B ^a   LeCates, Susan L ^a   Hershey, Andrew D ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Headache pathophysiology; Migraine; Mitochondrial dysfunction

Indexed keywords

CARNITINE;

ADOLESCENT; ARTICLE; CARNITINE PALMITYLTRANSFERASE II DEFICIENCY; CASE REPORT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME DEFICIENCY; FATIGUE; FEMALE; HUMAN; MIGRAINE; MUSCLE BIOPSY; MUSCLE CRAMP; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN BIOPSY; SYMPTOMATOLOGY;

ADOLESCENT; CARNITINE; CARNITINE O-PALMITOYLTRANSFERASE; FEMALE; HUMANS; MIGRAINE DISORDERS; MUSCLE, SKELETAL;

EID: 0037651342     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03095.x     Document Type: Article

References (22)

1. Abu-Arafeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309:765-769.
2. Hsu C, Chuang Y, Tsai JL, et al. CPEO and carnitine deficiency overlapping in MELAS syndrome. Acta Neurol Scand. 1995;92:252-255.
3. Gilles L, Adams RD, Edwin K. Childhood and Adolescent Hereditary Metabolic Disorders. 2nd ed. New York, NY: McGraw-Hill; 1996.
4. Wanic-Kossowska M. Protective role of carnitine in acetate metabolism of patients with uremia treated by hemodialysis. Pol Arch Med Wewn. 1997;97:534-540.
5. Triggs WJ, Roe CR, Rhead WJ, Hanson SK, Lin SZ, Willmore LJ. Neuropsychiatric manifestations of defect in mitochondrial beta-oxidation response to riboflavin. Neurol Neurosurg Psychiatry. 1992;55:209-211.
6. Montagna P, Cortelli P, Barbiroli B. Magnetic resonance spectroscopy studies in migraine. Cephalalgia. 1994;14:184-193.
7. Montagna P, Cortelli P, Monari L, et al. 31P-magnetic resonance spectroscopy in migraine without aura. Neurology. 1994;44:666-669.
8. Montagna P. Magnetic resonance spectroscopy in migraine. Cephalalgia. 1995;15:323-327.
9. Barbiroli B, Montagna P, Cortelli P, et al. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology. 1992;42: 1209-1214.
10. Vecino AM, Alvarez-Cermeno JC, Jimenez-Huete A, Navarro JL, Cesar JM. Lipid composition of platelets in patients suffering from migraine without aura. Headache. 1996;36:440-441.
11. Okada H, Araga S, Takeshima T, Nakashima K. Plasma lactic acid and pyruvic acid levels in migraine and tension-type headache. Headache. 1998;38:39-42.
12. Powers SW, Mitchell MJ, Byars KC, Bentti AL, LeCates SL, Hershey AD. A pilot study of one-session biofeedback training in pediatric headache. Neurology. 2001;56:133.
13. Binienda ZK, Ali SF. Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity. Toxicol Lett. 2001;125:67-73.
14. Athanassakis I, Zarifi I, Evangeliou A, Vassiliadis S. L-carnitine accelerates the in vitro regeneration of neural network from adult murine brain cells. Brain Res. 2002;932:70-78.
15. Welch K. Pathogenesis of migraine. Semin Neurol. 1997;17:335-341.
16. Welch K. Current opinions in headache pathogenesis: introduction and synthesis. Curr Opin Neurol. 1998;11:193-197.
17. Raskind JY, El-Chaar GM. The role of carnitine supplementation during valproic acid therapy. Ann Pharmacother. 2000;34:630-638.
18. Bohan TP, Helton E, McDonald I, et al. Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology. 2001;56:1405-1409.
19. Silberstein SD. Preventive treatment of migraine: an overview. Cephalalgia. 1997;17:67-72.
20. Silberstein SD, Collins SD. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group. Headache. 1999;39:633-643.
21. Mathew N, Saper J, Silberstein S, et al. Migraine prophylaxis with divalproex. Arch Neurol. 1995;52: 281-286.
22. Pakalnis A, Greenberg G, Drake ME Jr, Paolichi J. Pediatric migraine prophylaxis with divalproex. J Child Neurol. 2001;16:731-734.